Skip to main content

Corporate insider profile

William Grossman Insider Trades

Latest reported as Interim Chief Medical Officer of enGene Therapeutics Inc. (ENGN).

Purchase filings
1
Reported companies
1
Net open-market value
$10,051
Latest transaction
Sep 22, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 22, 2026enGene Therapeutics Inc. (ENGN)Interim Chief Medical OfficerOpen Market Purchase5,102$1.97$10,051